Marimed Stock Price, News & Analysis

MariMed (CSE: MRMD / OTCQX: MRMD) announced manufacturing and distribution agreements to launch hemp-derived THC versions of its beverage and edibles brands, including Vibations and Betty’s Eddies.

A hemp-derived THC Vibations drink mix is expected to be available in Rhode Island by early Q1 2026. The agreements establish an end-to-end hemp THC supply chain and create a new business unit, MMA Hemp Inc.

Partners named include DeHydr8 (manufacturing tech), Countermeasures (national sales/marketing), and Craft Collective Homegrown (Rhode Island distribution). According to BDSA, the hemp beverage market was $3.3B in 2024 and is projected to nearly double by 2029. Vibations and Betty’s Eddies are cited as top-selling brands in MariMed core markets.

MariMed (CSE: MRMD / OTCQX: MRMD) announced it has completed a strategic review and is exiting the Missouri market, effective immediately.

Since 2024 the company managed another licensed operator's Missouri facility under a Managed Services and Licensing Agreement while awaiting a license transfer; MariMed will no longer manage the facility or pursue the license transfer. The company continues to own or manage revenue-generating operations in six states, including 13 dispensaries and six cultivation and processing facilities across Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania. MariMed said the exit is expected to improve gross margin and adjusted EBITDA and let management redeploy resources to higher-return core markets. Management said it may consider future licensing with a vertical operator in Missouri if financially sensible.

MariMed (CSE: MRMD / OTCQX: MRMD) announced a licensing agreement with Farm 2 Hand to introduce MariMed’s top-selling edibles across New York State.

Farm 2 Hand will manufacture and distribute Betty’s Eddies™, Bubby’s Baked™, and InHouse™ gummies from a new kitchen that MariMed will design and equip at Farm 2 Hand’s Bronx facility. Terms were not disclosed. MariMed expects products to reach New York’s 500+ dispensaries in 2026, pending the kitchen build-out and regulatory approval. The company cited New York’s $6 billion total addressable market as a strategic expansion opportunity to drive wholesale revenue and brand awareness.

MariMed (OTCQX:MRMD) has launched the second annual Help on the Homefront campaign through its InHouse cannabis brand, offering veterans a chance to win financial support for housing costs. From October 1 to November 30, 2025, qualifying veterans in Maryland, Massachusetts, Delaware, and Illinois can enter to win $5,000 to help with housing expenses or home improvements.

The campaign, accessible through MariMed's Thrive dispensaries or online at inhousecannabis.com/veterans, will select one winner from each market before year-end. No purchase is necessary, and friends and family can submit entries on veterans' behalf. The initiative aims to address veteran housing challenges and homelessness while demonstrating MariMed's commitment to community support.

MariMed (OTCQX: MRMD), a prominent cannabis consumer packaged goods company and retailer, has scheduled its third quarter 2025 financial results announcement for November 5, 2025, after market close.

The company will host a conference call to discuss the results on November 6, 2025, at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available following the call.

MariMed's (OTCQX: MRMD) Betty's Eddies brand announced its third annual collaboration with the Keep A Breast Foundation (KAB) for Breast Cancer Awareness Month. The partnership features a limited-edition pink package of Ache Away Eddies cannabis fruit chews, available in Massachusetts, Maryland, Illinois, and Delaware.

The campaign promotes the free Keep A Breast app for self-checking education and medical professional connections. Betty's Eddies will distribute limited-edition merchandise and donate $5 from each t-shirt sale to KAB. Additionally, team members will participate in Susan G. Komen More Than Pink Walks in Maryland (October 11) and Massachusetts (October 18).

MariMed Inc. (OTCQX: MRMD) reported its Q2 2025 financial results, showing mixed performance. Revenue reached $39.6 million, slightly down from $40.4 million in Q2 2024. The company posted a GAAP net loss of $1.3 million but achieved non-GAAP Adjusted EBITDA of $4.9 million, up from $4.4 million year-over-year.

Key operational highlights include launching Nature's Heritage™ products in Illinois, introducing new Betty's Eddies™ caramel chews, and expanding to Maine through a licensing partnership. The company also announced a significant Managed Services Agreement in Pennsylvania with TILT Holdings, positioning for potential adult-use market expansion.

Despite challenges, MariMed maintained strong gross margins of 40% GAAP and 42% non-GAAP, while implementing its 'Expand the Brand' strategy across core markets.

MariMed (OTCQX: MRMD) has entered into a strategic Management Services Agreement (MSA) with TILT Holdings' subsidiary Standard Farms to expand into Pennsylvania's medical marijuana market. Starting September 1, 2025, MariMed will manage TILT's cultivation and processing facility in White Haven, Pennsylvania.

Under the 4-year agreement, MariMed will receive a 12.5% management fee of Standard Farms' gross revenue. The company will oversee daily operations, including budgeting, financial planning, compliance, and quality management. Additionally, Standard Farms will produce and distribute MariMed's branded products in Pennsylvania through a licensing arrangement.

MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers, with medical sales representing over half of Maine's cannabis revenues in 2024.

Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients through The Stoned Moose's dual-license capabilities. The brand currently holds market leadership in edibles across Massachusetts, Maryland, and Delaware, targeting Maine's local consumer base and its 15 million annual tourists.